Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-10 4:14 pm Sale | 13G | ALX ONCOLOGY HLDGS INC ALXO | MILLENNIUM MANAGEMENT LLC | 2,002,374 3.800% | -959,297 (-32.39%) | View |
| 2024-08-22 4:00 pm Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | TANG CAPITAL PARTNERS LP | 4,040,800 7.700% | 4,040,800 (New Position) | View |
| 2024-08-13 4:17 pm Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | MILLENNIUM MANAGEMENT LLC | 2,961,671 5.600% | 2,961,671 (New Position) | View |
| 2024-02-14 7:45 pm Sale | 13G | ALX ONCOLOGY HLDGS INC ALXO | ORBIMED ADVISORS LLC | 2,255,000 4.500% | -11,000 (-0.49%) | View |
| 2024-02-14 7:28 pm Sale | 13D | ALX ONCOLOGY HLDGS INC ALXO | LSV Associates LLC | 2,949,580 5.900% | -1,259,395 (-29.92%) | View |
| 2024-02-14 4:26 pm Sale | 13G | ALX ONCOLOGY HLDGS INC ALXO | Redmile Group LLC | 4,909,264 9.600% | -82,281 (-1.65%) | View |
| 2024-02-09 08:35 am Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | FMR LLC | 7,472,821 14.999% | 1,359,393 (+22.24%) | View |
| 2023-12-19 5:38 pm Sale | 13D | ALX ONCOLOGY HLDGS INC ALXO | LSV Associates LLC | 4,208,975 8.400% | -512,015 (-10.85%) | View |
| 2023-10-16 5:15 pm Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | Redmile Group LLC | 4,991,545 9.600% | 4,991,545 (New Position) | View |
| 2023-10-13 4:00 pm Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | Cormorant Asset Management LP | 3,142,079 6.310% | 3,142,079 (New Position) | View |
| 2023-02-14 4:06 pm Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | ORBIMED ADVISORS LLC | 2,266,000 5.600% | 2,266,000 (New Position) | View |
| 2023-02-09 08:23 am Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | FMR LLC | 6,113,428 15.000% | 1,832,912 (+42.82%) | View |
| 2022-08-10 08:10 am Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | FMR LLC | 4,280,516 10.522% | 1,687,577 (+65.08%) | View |
| 2022-06-10 10:14 am Sale | 13G | ALX ONCOLOGY HLDGS INC ALXO | WELLINGTON MANAGEMENT GROUP LLP | 1,128,101 2.770% | -2,600,229 (-69.74%) | View |
| 2022-02-09 09:09 am Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | FMR LLC | 2,592,939 6.402% | 2,592,939 (New Position) | View |
| 2022-02-04 09:12 am Sale | 13G | ALX ONCOLOGY HLDGS INC ALXO | WELLINGTON MANAGEMENT GROUP LLP | 3,728,330 9.210% | -476,797 (-11.34%) | View |
| 2021-09-10 08:54 am Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | WELLINGTON MANAGEMENT GROUP LLP | 4,205,127 10.420% | 4,205,127 (New Position) | View |
| 2021-06-15 12:19 pm Purchase | 13D | ALX ONCOLOGY HLDGS INC ALXO | Logos Global Management LP | 3,156,981 7.900% | 76,080 (+2.47%) | View |
| 2020-10-01 10:01 am Purchase | 13D | ALX ONCOLOGY HLDGS INC ALXO | venBio Global Strategic Fund II L.P. | 9,799,331 26.900% | 9,799,331 (New Position) | View |
| 2020-08-25 7:08 pm Purchase | 13D | ALX ONCOLOGY HLDGS INC ALXO | Logos Global Management LP | 3,080,901 8.400% | 3,080,901 (New Position) | View |